Real World Evaluation of Next-Day Molecular Respiratory Infectious Disease Testing on Healthcare Resource Utilization and Costs
Next-day molecular testing for respiratory and oropharyngeal infection lowers healthcare utilization and costs, suggesting improved patient care through reduced need for healthcare resources.
Authors
- Pallavi Upadhyay (ORCID: https://orcid.org/0009-0008-1005-5503)
- Azia S. Evans (ORCID: https://orcid.org/0000-0002-8309-5222)
- Maren S. Fragala (ORCID: https://orcid.org/0000-0001-6025-7025)
- Andrea French (ORCID: https://orcid.org/0000-0002-1210-4857)
- Jairus Reddy
- Steven Goldberg
Publication Details
- Journal
- ClinicoEconomics and Outcomes Research
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/ceor.s497838
- Citations
- 2
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 2.71